Table III.
Subgroup | No. of pairs |
Endpoint in treatment |
Endpoint in control |
PSM | LR | ||
---|---|---|---|---|---|---|---|
OR (CI) | p | OR (CI) | p | ||||
15-59 | 4,106 | 350 (8.5%) | 435 (10.6%) | 0.78 (0.67-0.91) | 0.002 | 0.73 (0.65-0.82) | <0.001 |
60-74 | 6,813 | 656 (9.6%) | 803 (11.8%) | 0.80 (0.71-0.89) | <0.001 | 0.79 (0.73-0.87) | <0.001 |
75- | 5,405 | 206 (3.8%) | 253 (4.7%) | 0.81 (0.67-0.97) | 0.028 | 0.75 (0.65-0.87) | <0.001 |
Male | 7,141 | 583 (8.2%) | 750 (10.5%) | 0.76 (0.67-0.85) | <0.001 | 0.72 (0.66-0.79) | <0.001 |
Female | 9,183 | 629 (6.8%) | 718 (7.8%) | 0.87 (0.77-0.97) | 0.012 | 0.84 (0.77-0.92) | <0.001 |
BMI ≥30 | 3,486 | 447 (12.8%) | 474 (13.6%) | 0.93 (0.81-1.07) | 0.352 | 0.89 (0.80-0.99) | 0.026 |
BMI <30 | 12,838 | 765 (6.0%) | 933 (7.3%) | 0.81 (0.73-0.89) | <0.001 | 0.74 (0.69-0.80) | <0.001 |
Delta wave | 3,881 | 355 (9.1%) | 408 (10.5%) | 0.85 (0.73-0.99) | 0.044 | 0.76 (0.68-0.86) | <0.001 |
Omicron wave | 3,329 | 203 (6.1%) | 222 (6.7%) | 0.91 (0.74-1.11) | 0.37 | 0.80 (0.69-0.93) | 0.004 |